CARRINGTON LABS I, (CARN) Stock Research Free Stock Rating

Company Profile

Carrington Laboratories, Inc. operates as a research-based biopharmaceutical and consumer products company in the United States and internationally. The company manufactures and markets products for mucositis, radiation dermatitis, and wound and oral care utilizing the naturally-occurring polymeric carbohydrates. It operates in three divisions: Medical Services Division, Consumer Services Division, and DelSite Biotechnologies, Inc. The Medical Services Division sells medical products and provides manufacturing services to customers in medical markets. It offers various products comprising hydrogels, wound cleansers, hydrocolloids, advanced wound covering products, and incontinence-care products, which contain its proprietary medical-grade raw material Acemannan Hydrogel. The Consumer Services Division offers a nutraceutical raw material Manapol and other proprietary and nonproprietary raw materials to the nutraceutical and cosmetic customers; nutritional products under the AloeCeuticals brand; and skin care products under the Snow or Sun brand. This division also markets the bulk raw material Hydrapol powder to manufacturers of bath, beauty, and skin care products, as well as manufactures private-labeled products consisting of powders, creams, liquids, gels, drinks, tablets, and capsules to customer specifications. The company, through its subsidiary, DelSite Biotechnologies, Inc., engages in the research, development, and marketing of its proprietary GelSite technology for controlled release and delivery of bioactive pharmaceutical ingredients. Carrington Laboratories was founded in 1973 under the name Ava Cosmetics, Inc. and changed its name to Carrington Laboratories, Inc. in 1986. The company is headquartered in Irving, Texas.

Latest Headlines